ALBCURA CORPORATION
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
Albcura’s flagship product line, deAlbumin™, is recombinant human serum albumin (rHSA) produced in yeast (e.g., Pichia pastoris), formulated with a well-defined recipe to eliminate plasma-derived impurities and ensure batch-to-batch consistency. This enab
The content above was translated by Ai
Founded Year
2017
Unified Business No.
52534104
Status
Active
Number of Employees
0
Total Paid-in
Capital
189,952,920 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Albcura Corporation, headquartered in Taiwan, is a biotechnology startup specializing in the development and production of high-quality, animal-component-free recombinant human serum albumin (rHSA). Their products are designed for applications in cell culture, pharmaceutical excipients, and bioprocessing. Operating under an ISO 13485 certified quality system, Albcura pursues scientific innovation to deliver consistent, reliable protein reagents for both research and clinical use.
The content above was translated by Ai
